On 4 July, the world health organization announced the termination of trials of hydroxychloroquine and the combination of the drugs lopinavir and ritonavir, which were conducted to search for drugs effective against coronavirus disease COVID-19. About it it is reported on the who website.
Recommendations to stop the test gave the international steering Committee of test of solidarity who.
“Intermediate test results show that the hydroxychloroquine and lopinavir / ritonavir lead to a slight reduction in mortality among hospitalized patients with COVID-19 or even not reduce it”, – stated in the message.
The who noted that these conclusions refer only to research on hospitalized patients and does not affect the possible evaluation of the efficacy of hydroxychloroquine or lopinavir / ritonavir have negosudarstvennyh patients or as prophylaxis COVID-19.
In may of the admission of hydroxychloroquine as a preventive measure against coronavirus was declared by the President of the United States Donald trump. Later, he promised to stop taking the drug.
At the end of may in the prestigious medical journal the Lancet published a Preprint of the study, stating that the hydroxychloroquine seriously increase the risk of death in patients with COVID-19 (later, the authors withdrew the study because of questions about the reliability of the analyzed data).
After the publication of the study by the world health organization has suspended trials of hydroxychloroquine. June 3, testing was resumed. “Based on available data about mortality of the members of the Committee for security and monitoring data concluded that there is no reason to change the treatment Protocol. The Executive team had received the recommendation and approved the continuation of all clinical trials, including hydroxychloroquine,” – said the Director General of the who tedros adhanom Ghebreyesus.
May 1 the drug from Ebola ramdevpir in the United States were allowed to apply to adults and children hospitalized with COVID-19, who are in serious condition. Ramdevpir – the first remedy, since June 25, are allowed to apply in the European Union during coronavirus infection in adults and adolescents from 12 years of age. Drug ramdevpir included in the Ukrainian Protocol of treatment of coronavirus infection COVID-19.
Flash coronavirus infection COVID-19 began in December 2019 in the Chinese city of Wuhan. March 11, 2020, the world health organization declared the spread of the coronavirus pandemic.